Polycyclic-carbamoyl pyridinone compounds and pharmaceutical uses thereof
CN116640140BActive Publication Date: 2026-08-28GILEAD SCIENCES INC
Patent Information
- Application Number
- CN202310322212.0
- Authority / Receiving Office
- CN · China
- Patent Type
- Patents(China)
- Current Assignee / Owner
- Priority Date
- 2013-07-12
- Filing Date
- 2013-12-19
- Publication Date
- 2026-08-28
- Estimated Expiration
- 2033-12-19
Smart Images
Figure CN116640140B_ABST
Abstract
Disclosed are compounds useful for the treatment of human immunodeficiency virus (HIV) infection. The compounds have the following formula (I): including stereoisomers and pharmaceutically acceptable salts thereof, wherein R 1 , X, W, Y 1 , Y 2 , Z 1 , and Z 4 are as defined herein. Also disclosed are methods relating to the preparation and use of such compounds and pharmaceutical compositions comprising such compounds.
Need to check novelty before this filing date? Find Prior Art
Citation Information
Patent Citations
Polycyclic-carbamoylpyridone compounds and their pharmaceutical use
CN111303152A
Small Molecule Modulators of HIV-1 Capsid Stability and Methods Thereof
US20130165489A1
Furopyridine, thienopyridine, pyrrolopyridine and related pyrimidine, pyridazine and triazine compounds useful in controlling chemical synaptic transmission
WO1997005139A1
Inhibitors of human immunodeficiency virus replication
WO2009062285A1
Inhibitors of human immunodeficiency virus replication
WO2010130034A1